Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Primary Sjögren's Syndrome
NCT00363350Phase 2Completed
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2006
- Primary completion
- Oct 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in primary Sjögren's syndrome, sponsored by University Medical Center Groningen. Started Aug 2006; status: completed.
02
Drugs
rituximab
03
Conditions
primary Sjögren's syndrome
Beyond the preview
Go deeper on NCT00363350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00363350.